Romilkimab (Anti-IL-13 & IL-4)
Product Specifications
CAS Number
1399584-78-1
Synonyms
SAR156597
Target
Interleukins
Applications
Immunology & Inflammation
Additionnal Information
Romilkimab is a humanized bispecific immunoglobulin-G4 antibody that targets and neutralizes IL-4 and IL-13, effectively downmodulating the inflammatory response. Its treatment significantly reduces thymus and activation-regulated chemokine (TARC) levels in patients with idiopathic pulmonary fibrosis (IPF) and significantly decreases the modified Rodnan skin score (mRSS) in patients with diffuse cutaneous systemic sclerosis (dcSSc) . MW: 198.16 KD.
Storage Conditions
-80°C (avoid freeze-thaw cycles)
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC682845-100 1x 100 µL
EGFR (Epidermal Growth Factor Receptor) (R1), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
![3,3'-(1,4-Phenylene)bis[5,6-diphenyl-1,2,4-triazine]](https://cdn.genprice.uk/products/572/12171007/imageurl/trc-p054990-100mg.webp)
TRC-P054990-100MG 100 mg
3,3'-(1,4-Phenylene)bis[5,6-diphenyl-1,2,4-triazine]
Sign In for Pricing
View Details 
BNC740416-500 1x 500 µL
Fascin-1 (FSCN1/416), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
